OTCBB:PMCB

Pharmacyt Biotch Stock Insider Trading

etoro logo Buy PMCB
*Your capital is at risk
$0.751
-0.0489 (-6.11%)
At Close: Jun 02, 2026

Pharmacyt Biotch Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 73.78. In total, the insiders bought 5.2M and sold 393.75K PMCB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
73.78
Buy 5.2M shares
Sell 393.75K shares
95% Buy Activity
Moderate Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 31, 2026
Buy
Stock Option (Right to Buy)
A-Award
Weinstein Robert
Director
Director 119 170
Value: $79.8K
Mar 31, 2026
Buy
Stock Option (Right to Buy)
A-Award
Walker Wayne Remell
Director
Director 119 170
Value: $79.8K
Mar 31, 2026
Buy
Stock Option (Right to Buy)
A-Award
Schechter Jonathan
Director
Director 119 170
Value: $79.8K
Mar 31, 2026
Buy
Stock Option (Right to Buy)
A-Award
Abecassis Michael M
Director
Director 119 170
Value: $79.8K
Jan 07, 2026
Buy
Common Stock
P-Purchase
Silverman Joshua
CEO And President
CEO / President 40 000
Value: $33.3K
Jan 07, 2026
Buy
Common Stock
P-Purchase
Schechter Jonathan
Director
Director 20 000
Value: $16.9K
Jan 06, 2026
Buy
Common Stock
P-Purchase
Silverman Joshua
CEO And President
CEO / President 30 000
Value: $23.7K
Jan 06, 2026
Buy
Common Stock
P-Purchase
Schechter Jonathan
Director
Director 20 000
Value: $15.8K
Jan 05, 2026
Buy
Common Stock
P-Purchase
Silverman Joshua
CEO And President
CEO / President 30 000
Value: $23.5K
Jan 05, 2026
Buy
Common Stock
P-Purchase
Schechter Jonathan
Director
Director 20 000
Value: $15.6K
Dec 12, 2025
Buy
Common Stock
A-Award
Weinstein Robert
Director
Director 75 000
Value: $76.5K
Dec 12, 2025
Sell
Common Stock
F-InKind
Weinstein Robert
Director
Director 33 750
Value: $34.4K
Dec 12, 2025
Buy
Common Stock
A-Award
Walker Wayne Remell
Director
Director 37 500
Value: $38.3K
Dec 12, 2025
Sell
Common Stock
F-InKind
Walker Wayne Remell
Director
Director 16 875
Value: $17.2K
Dec 12, 2025
Buy
Common Stock
A-Award
Silverman Joshua
CEO And President
CEO / President 575 000
Value: $586.5K
Dec 12, 2025
Sell
Common Stock
F-InKind
Silverman Joshua
CEO And President
CEO / President 258 750
Value: $263.9K
Dec 12, 2025
Buy
Common Stock
A-Award
Schechter Jonathan
Director
Director 150 000
Value: $153.0K
Dec 12, 2025
Sell
Common Stock
F-InKind
Schechter Jonathan
Director
Director 67 500
Value: $68.9K
Dec 12, 2025
Buy
Common Stock
A-Award
Abecassis Michael M
Director
Director 37 500
Value: $38.3K
Dec 12, 2025
Sell
Common Stock
F-InKind
Abecassis Michael M
Director
Director 16 875
Value: $17.2K
Apr 25, 2025
Buy
Stock Option (Right to Buy)
A-Award
Weinstein Robert
Director
Director 63 233
Value: $77.1K
Apr 25, 2025
Buy
Stock Option (Right to Buy)
A-Award
Walker Wayne Remell
Director
Director 63 233
Value: $77.1K
Apr 25, 2025
Buy
Stock Option (Right to Buy)
A-Award
Schechter Jonathan
Director
Director 63 233
Value: $77.1K
Apr 25, 2025
Buy
Stock Option (Right to Buy)
A-Award
Abecassis Michael M
Director
Director 63 233
Value: $77.1K
Apr 30, 2024
Buy
Stock Option (Right to Buy)
A-Award
Weinstein Robert
Director
Director 38 009
Value: $80.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PHARMACYT BIOTCH
Pharmacyt Biotch
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. The company is developin...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE